1Xian J, Lin Y, Liu Y, et al. Combined p14ARF and antisense EGFR potentiate the efficacy of adenovirus-mediated gene therapy in laryngeal squamous cell carcinoma ( LSCC ) [ J ]. DNA Cell Biol, 2007,26 (2):71.
2Kuo ML, Duncavage E J, Mathew R, et al. Arf induces P53-dependent and -independent antiproliferative genes [ J ]. Cancer Res, 2003,63 (5) :1046.
3Pham TT, Ongkeko WM, An Y. Protein expression of the tumor suppressors p16INK4A and p53 and disease progression in recurrent respiratory papillomatosis[ J]. Laryngoscope ,2007,117 (2) :253.
4Le Frere Belda MA, Gil Diez de Medina S, Daher A, et al. Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status[ J]. Hum Pathol,2004,35 (7) :817.
5Kumamoto H, Izutsu T, Ohki K. p53 gene status and expression of p53,MDM2,and p14 proteins in ameloblastomas [ J ]. J Oral Pathol Med ,2004,33 ( 5 ) :292.
6Parisi T,Pollice A, Di Cristofano A. Transcriptional regulation of the human tumor suppressor p14 (ARF) by E2F1, E2F2 i E2F3, and Sp1 -like factors [J]. Biochem Biophys Res Commun, 2002,291 ( 5 ) : 1138.
7Rizos H, Darmanian AP, Mann GJ. Two arginine rich domains in the p14ARF turnout suppressor mediate nucleolar localization [ J ]. Oncogene,2000,19(26) :2978.
8Rizos H,Scurr LL, Irvine M,et al. p14ARF regulates E2F-1 ubiquitination and degradation via a p53-dependent mechanism [ J ]. Cell Cycle,2007,6 (14) : 1741.
